Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alieva

Showing results (511-520 of 518) with videos related to

Pageof 52
Sort By:
You have reached the last page of results.This site can display upto 518 results.
Nature Biotechnology|July 25, 2022
Uncovering the mode of action of engineered T cells in patient cancer organoidsJohanna F Dekkers, Maria Alieva, Astrid Cleven, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 13, 2026
'What' and 'How' to Measure in Allergy and Clinical Immunology: A Systematic Review of Core Outcome Sets and Outcome Harmonisation ProcessesAnastasia Demidova, Nata Kiknavelidze, Kristine Purtskhvanidze, et al.
Breast Cancer Research and Treatment|October 18, 2023
Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North CaucasusAnna P Sokolenko, Elvina Kh Bakaeva, Aigul R Venina, et al.
Terapevticheskii Arkhiv|September 16, 2017
[The Russian consensus on the diagnosis and treatment of chronic pancreatitis: Enzyme replacement therapy]I E Khatkov, I V Maev, D S Bordin, et al.
Kardiologiia|September 12, 2024
Patients With Non-Obstructive Coronary Artery Disease and Polyvascular Disease. Sub-Analysis of the Real-World Registry KAMMA (Clinical Registry on Patient Population With Polyvascular Disease in the Russian Federation and Eurasian Countries)G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.
Terapevticheskii Arkhiv|October 26, 2022
[ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis]G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.
Kardiologiia|October 29, 2021
Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)E I Tarlovskaya, A G Arutyunov, A O Konradi, et al.
Problemy Endokrinologii|January 23, 2023
[The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries]A G Arutyunov, E I Tarlovskaya, G R Galstyan, et al.
Pageof 52

Showing results (511-520 of 518) with videos related to

Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 518 results.
Nature Biotechnology|July 25, 2022
Uncovering the mode of action of engineered T cells in patient cancer organoidsJohanna F Dekkers, Maria Alieva, Astrid Cleven, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 13, 2026
'What' and 'How' to Measure in Allergy and Clinical Immunology: A Systematic Review of Core Outcome Sets and Outcome Harmonisation ProcessesAnastasia Demidova, Nata Kiknavelidze, Kristine Purtskhvanidze, et al.
Breast Cancer Research and Treatment|October 18, 2023
Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North CaucasusAnna P Sokolenko, Elvina Kh Bakaeva, Aigul R Venina, et al.
Terapevticheskii Arkhiv|September 16, 2017
[The Russian consensus on the diagnosis and treatment of chronic pancreatitis: Enzyme replacement therapy]I E Khatkov, I V Maev, D S Bordin, et al.
Kardiologiia|September 12, 2024
Patients With Non-Obstructive Coronary Artery Disease and Polyvascular Disease. Sub-Analysis of the Real-World Registry KAMMA (Clinical Registry on Patient Population With Polyvascular Disease in the Russian Federation and Eurasian Countries)G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.
Terapevticheskii Arkhiv|October 26, 2022
[ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis]G P Arutyunov, E I Tarlovskaya, A G Arutyunov, et al.
Kardiologiia|October 29, 2021
Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)E I Tarlovskaya, A G Arutyunov, A O Konradi, et al.
Problemy Endokrinologii|January 23, 2023
[The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries]A G Arutyunov, E I Tarlovskaya, G R Galstyan, et al.
Pageof 52